FDA Approves Symbravo for Acute Treatment of Migraine in Adults
2025-02-05
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severityContinue Reading
FDA Approves Susvimo for Diabetic Macular Edema
2025-02-05
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injectionsContinue Reading
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
2025-02-05
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
Many Americans Misguided On Daily Aspirin, Survey Finds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
Heart Patients Aren’t Taking Lifesaving Meds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FDA Approves First New Non-Opioid Pain Pill in Decades
2025-01-31
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading
Daily Aspirin Reduces Colon Cancer Risk: Study
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutationContinue Reading
COVID-19 Remains Major Health Threat in U.S.
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. VeteransContinue Reading
COVID Vaccine Hesitancy Reducing Childhood Vaccinations
2025-01-24
FRIDAY, Jan. 24, 2025 (HealthDay News) — Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children. Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard measles/mumps/rubella (MMR) vaccine, researchers reported in a new studyContinue Reading
Medical Weed Users At Risk for Addiction
2025-01-24
FRIDAY, Jan. 24, 2025 (HealthDay News) — People using weed for medical purposes are as likely – or more – to become addicted to cannabis as recreational tokers, a new study says. Folks using medical marijuana were more likely to have cannabis use disorder than those who get high recreationally,Continue Reading